Literature DB >> 22249207

Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV-positive women.

Florence Masaisa1, Candace Breman, Jean Bosco Gahutu, Joshua Mukiibi, Joris Delanghe, Jan Philippé.   

Abstract

The Q248H mutation in the gene SLC40A1 which encodes for the cellular iron exporter ferroportin is relatively common in Africa. This mutation has been associated with resistance to hepcidin and therefore we hypothesized that iron-related parameters and the prevalence of opportunistic infections in HIV might be influenced by the Q248H mutation. We conducted a cross-sectional study among 200 HIV-positive women in the Butare University Teaching Hospital in Rwanda. Polymerase chain reaction (PCR) and restriction enzyme digestion were used to identify the Q248H mutation. Physical examination was carried out and WHO HIV disease stage classification, complete blood count, CD4 count, indirect measures of iron status, serum hepcidin, and C-reactive protein concentrations were determined. The prevalence of ferroportin Q248H mutation was 6%. Subjects with ferroportin Q248H mutation had significantly higher values for serum ferritin (P = 0.001) and significantly lower values for serum hepcidin (P = 0.001) and transferrin (P = 0.01). Among the 12 HIV + Q248H heterozygotes, 8 suffered from at least one opportunistic infection. There was significantly higher prevalence of pulmonary TB (P = 0.01) and Pneumocystis jiroveci pneumonia (P = 0.02) in subjects with ferroportin Q248H mutation. Low hepcidin levels were found in ferroportin Q248H heterozygotes with HIV infection, notwithstanding the absence of anemia and the higher prevalence of some opportunistic infections. Hepcidin seems to be regulated in a different way in Q248H heterozygotes than is known thus far.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249207     DOI: 10.1007/s00277-011-1400-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  10 in total

1.  Sequestration and scavenging of iron in infection.

Authors:  Nermi L Parrow; Robert E Fleming; Michael F Minnick
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

2.  Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.

Authors:  Sergei Nekhai; Min Xu; Altreisha Foster; Ishmael Kasvosve; Sharmin Diaz; Roberto F Machado; Oswaldo L Castro; Gregory J Kato; James G Taylor; Victor R Gordeuk
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

3.  Anemia, Iron Status, and HIV: A Systematic Review of the Evidence.

Authors:  Ajibola I Abioye; Christopher T Andersen; Christopher R Sudfeld; Wafaie W Fawzi
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

4.  HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response.

Authors:  Sergei Nekhai; Namita Kumari
Journal:  Expert Rev Hematol       Date:  2022-03-24       Impact factor: 2.819

5.  Differences in the frequency of genetic variants associated with iron imbalance among global populations.

Authors:  Momodou W Jallow; Carla Cerami; Taane G Clark; Andrew M Prentice; Susana Campino
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

6.  Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.

Authors:  Gautam Rishi; Eriza S Secondes; Daniel F Wallace; V Nathan Subramaniam
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

7.  The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia.

Authors:  John Muthii Muriuki; Alexander J Mentzer; Gavin Band; James J Gilchrist; Tommy Carstensen; Swaib A Lule; Morgan M Goheen; Fatou Joof; Wandia Kimita; Reagan Mogire; Clare L Cutland; Amidou Diarra; Anna Rautanen; Cristina Pomilla; Deepti Gurdasani; Kirk Rockett; Neema Mturi; Francis M Ndungu; J Anthony G Scott; Sodiomon B Sirima; Alireza Morovat; Andrew M Prentice; Shabir A Madhi; Emily L Webb; Alison M Elliott; Philip Bejon; Manjinder S Sandhu; Adrian V S Hill; Dominic P Kwiatkowski; Thomas N Williams; Carla Cerami; Sarah H Atkinson
Journal:  Sci Adv       Date:  2019-09-04       Impact factor: 14.136

8.  An 8-ferroptosis-related genes signature from Bronchoalveolar Lavage Fluid for prognosis in patients with idiopathic pulmonary fibrosis.

Authors:  Yaowu He; Yu Shang; Yupeng Li; Menghan Wang; Dongping Yu; Yi Yang; Shangwei Ning; Hong Chen
Journal:  BMC Pulm Med       Date:  2022-01-05       Impact factor: 3.317

9.  Ferroportin Q248H mutation was not found to be protective against malaria and anemia in children under 5 years living in South Kivu/Democratic Republic of Congo, an endemic area of P lasmodium infection.

Authors:  Yvette Lufungulo Bahati; Joris Delanghe; Ghislain Bisimwa Balaluka; Karl Vandepoele; Justin Cikomola Cirhuza; Antoine Sadiki Kishabongo; Jan Philippé
Journal:  Heliyon       Date:  2022-08-28

10.  Inverse relationship of serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an Indonesian prospective cohort study.

Authors:  Rudi Wisaksana; Quirijn de Mast; Bachti Alisjahbana; Hadi Jusuf; Primal Sudjana; Agnes R Indrati; Rachmat Sumantri; Dorine Swinkels; Reinout van Crevel; Andre van der Ven
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.